Clinical Trial

The Impact of Inflammation on Skeletal Muscle Maintenance in Hospitalized Patients

Study acronym: InflaMus
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated April 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
The main goal is to elucidate the mechanistic coupling between inflammation and the ability to maintain skeletal muscle through physical exercise while hospitalized. We will investigate protein kinetics in patients who belong to one of three groups 1) high inflammatory state, 2) moderate inflammatory state and 3) low/no inflammation. We will further intervene in group 1 (high inflammatory state) with anti-inflammatory nutrition (primarily green-solution plant-based) to diminish activity in inflammatory pathways. The hypothesis is that inflammation will inhibit protein synthesis in skeletal muscle both in resting muscle and in strength trained skeletal musculature, and that a lowering of the inflammatory status by anti-inflammatory nutrition will enhance the exercise induced formation of new muscle mass. .
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-08.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-05-12
Trial Details
NCT Number NCT06967220
Lead Sponsor Bispebjerg Hospital
Conditions Disease Related Malnutrition, High Systemic Inflammation, Geriatric Assessment
Enrollment 90 participants
Start Date 2025-05-12
Primary Completion 2026-04-22 (estimated)
Study Completion 2026-04-22 (estimated)
Updated on ClinicalTrials.gov 2025-05-15